Jun, an Oncological Foe or Friend?

Zuhayr Jafri, Yue Li, Jingwen Zhang, Connor H. O’Meara, Levon M. Khachigian*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Jun/JUN is a basic leucine zipper (bZIP) protein and a prototypic member of the activator protein-1 (AP-1) family of transcription factors that can act as homo- or heterodimers, interact with DNA elements and co-factors, and regulate gene transcription. Jun is expressed by both immune and inflammatory cells. Jun is traditionally seen as an oncoprotein that regulates processes involved in transformation and oncogenesis in human tumours. This article examines the traditional view that Jun plays a permissive role in cancer development and progression, whilst exploring emerging evidence supporting Jun’s potential to prevent immune cell exhaustion and promote anti-tumour efficacy.

Original languageEnglish
Article number555
Number of pages15
JournalInternational Journal of Molecular Sciences
Volume26
Issue number2
DOIs
Publication statusPublished - Jan 2025

Fingerprint

Dive into the research topics of 'Jun, an Oncological Foe or Friend?'. Together they form a unique fingerprint.

Cite this